PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference

The leading global event in drug safety — the Pharmacovigilance World 2026 conference — and the industry portal PHARMPROM have agreed on a media partnership. The large-scale event, organized by Corvus Global Events, will take place on June 16–17, 2026, at the Hilton London Kensington in London (United Kingdom).

About the Conference

Pharmacovigilance World 2026 will serve as a unique knowledge-sharing and networking platform, bringing together researchers, healthcare professionals, pharma industry executives, and regulatory authorities.

Today, pharmacovigilance goes beyond simple regulatory reporting: it is about anticipating risks, protecting patients, and ensuring trust in healthcare. According to the organizers, the use of AI-powered safety systems already provides a 4x greater signal detection speed, and 75% of pharmacovigilance leaders are investing in automation for case processing and analytics. The main goal of the summit is to discuss these innovations to enhance global drug safety.

Key Themes to Be Discussed

The conference program covers 15 critical core topics defining the future of modern pharmacovigilance. Among them:

• Artificial Intelligence and Automation: integrating AI, machine learning, and natural language processing (NLP) to reduce manual workload and accurately identify signals.
• Regulatory Intelligence & Global Harmonization: understanding the evolving regulatory requirements from leading global regulators, including EMA, MHRA, FDA, PMDA, and WHO.
• Risk Management & Benefit-Risk Evaluation: designing and evaluating effective risk mitigation strategies throughout the product lifecycle.
• Post-Marketing Surveillance: strengthening real-world evidence (RWE) data through active and passive monitoring and patient-centric strategies.
• PV in Clinical Trials & Medical Devices: the specifics of safety reporting during early and late-stage clinical trials, as well as navigating unique challenges in PV for non-drug and combination products.
• PV Audits, Inspections & Readiness: achieving excellence in internal audits and health authority inspections, and maintaining robust PV systems.

Who Should Attend?

The conference is designed for a broad range of professionals: specialists in pharmacovigilance & drug safety, regulatory affairs experts, AI & data analytics developers, representatives of CROs, consulting firms, regulatory bodies, and patient safety advocates.